Improving care and understanding of Kaposi sarcoma in Zambia and Tanzania
Kaposi Sarcoma in the Era of ART in Africa Program (KEAAP)
Researchers are partnering with hospitals in Zambia, Tanzania, and the United States to improve diagnosis, treatment, and prevention of Kaposi sarcoma for people living with HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lsu Health Sciences Center NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project ID | NIH-11184252 on NIH RePORTER |
What this research studies
This program brings together cancer hospitals in Zambia and Tanzania with LSU Health Sciences Center-New Orleans to study Kaposi sarcoma in the era of antiretroviral therapy. Teams will connect clinical care with laboratory studies to learn how KS develops, how the immune system responds, and how treatments influence outcomes. The program also strengthens local cancer research and treatment capacity so hospitals can diagnose and manage KS more effectively. Patients at participating sites may be invited to join observational studies, contribute tissue or blood samples, and access improved care pathways.
Who could benefit from this research
Good fit: Ideal participants are people living with HIV in Zambia or Tanzania who have suspected or confirmed Kaposi sarcoma or who receive care at the participating cancer hospitals.
Not a fit: People who do not live in the participating regions, do not have HIV, or do not have Kaposi sarcoma are unlikely to directly benefit from this program.
Why it matters
Potential benefit: If successful, this work could lead to earlier detection, better treatments, and fewer deaths from Kaposi sarcoma among people with HIV in sub-Saharan Africa.
How similar studies have performed: Wider rollout of antiretroviral therapy has reduced some Kaposi sarcoma burden, but coordinated research networks and capacity-building efforts like this are less common and aim to fill remaining gaps.
Where this research is happening
New Orleans, United States
- Lsu Health Sciences Center — New Orleans, United States (Active)
Researchers
- Principal investigator: Wood, Charles — Lsu Health Sciences Center
- Study coordinator: Wood, Charles
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.